Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Emerging World Pharma, an investor in generic based pharmaceutical companies manufacturing within developing nations, has provided an initial investment into European Global Pharma that is expected to be used to fund a generic drug manufacturing facility in Estonia.
Subscribe to our email newsletter
Emerging World Pharma focuses its investments on generic pharmaceutical companies that have contracts with three major buyer groups; church, government and wholesalers.
The investment would entitle Emerging World Pharma to an initial 10% of profits obtained from the marketing and distribution of generic pharmaceuticals sold. The company retains an option to increase the percentage of profit on additional investments of up to 25%.